Literature DB >> 30292479

Phage therapy 2.0: where do we stand?

Roelf S Breederveld1.   

Abstract

Mesh：

Year:  2018        PMID： 30292479     DOI： 10.1016/S1473-3099(18)30502-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

1.  Eco-Evolutionary Effects of Bacterial Cooperation on Phage Therapy: An Unknown Risk?

Authors:  Adrián Cazares; Rodolfo García-Contreras; Judith Pérez-Velázquez
Journal:  Front Microbiol       Date:  2020-11-12       Impact factor: 5.640

2.  Contribution of Podoviridae and Myoviridae bacteriophages to the effectiveness of anti-staphylococcal therapeutic cocktails.

Authors:  Maria Kornienko; Nikita Kuptsov; Roman Gorodnichev; Dmitry Bespiatykh; Andrei Guliaev; Maria Letarova; Eugene Kulikov; Vladimir Veselovsky; Maya Malakhova; Andrey Letarov; Elena Ilina; Egor Shitikov
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.